About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
CNS Neuroscience and Therapeutics
›
Top Articles
CNS Neuroscience and Therapeutics
Neurology
,
Pharmacology
,
Biology
,
Neuroscience
,
Physiology
6.8
(top 2%)
Impact Factor
7.1
(top 2%)
extended IF
78
(top 5%)
H-Index
1.7K
authors
1.6K
papers
36.2K
citations
3.8K
citing journals
29.2K
citing authors
Most Cited Articles of CNS Neuroscience and Therapeutics
Title
Year
Citations
Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)
2013
317
REVIEW: Curcumin and Alzheimer's disease
2010
295
The pharmacology of lysergic acid diethylamide: a review
2008
255
A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
2011
243
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
2017
239
Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders
2010
232
Post-traumatic stress disorder in Canada
2008
193
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)
2009
192
Altered processing of contextual information during fear extinction in PTSD: an fMRI study
2011
190
Excessive autophagy contributes to neuron death in cerebral ischemia
2012
185
Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
2016
178
REVIEW: Neurosyphilis: A historical perspective and review
2010
176
The antiapoptotic activity of melatonin in neurodegenerative diseases
2009
176
The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties
2008
171
Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases
2008
171
REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy
2010
168
Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances
2012
166
Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders
2012
166
All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors
2011
160
Cannabidiol: a promising drug for neurodegenerative disorders?
2009
152
Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders
2009
152
Oxytocin levels in social anxiety disorder
2008
152
BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke
2014
146
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms
2010
140
Seizures and epilepsy in Alzheimer's disease
2012
139
previous
2016
2017
2018
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.